Search Media Items

TCGA cannot, under any circumstances, accommodate external requests for analytes or tissue materials.

An up-to-date list of publications by The Cancer Genome Atlas, including analyses performed after the original cancer type-specific studies were completed.

TCGA's Study of Glioblastoma Multiforme

A summary of TCGA's study of papillary renal cell (kidney) carcinoma, including what was known prior to the study and main findings from the characterization and analysis.

TCGA's Study of Lower Grade Glioma

TCGA's Study of Lung Squamous Cell Carcinoma

TCGA's Study of Ovarian Serous Adenocarcinoma

TCGA's Study of Paraganglioma & Pheochromocytoma

About a third of all cancers are driven by mutations in RAS genes. Learn how NCI funding is helping Dr. Kevan Shokat develop drugs that inactivate molecular drivers of cancer such as RAS.

While standard biological methods such as two-dimensional, in vitro cell culture and in vivo animal models are useful to examine certain biological questions, the complexity of cancer requires a continuum of model systems. This collaborative study will create a foundation for tumor tissue engineering by employing multiple innovative methodologies to first characterize and then build biomimetic models of the extracellular matrix (ECM) in the tumor microenvironment. The ECM is a key element in biomimicry, and particularly important to consider in the context of cancer, where the composition and architecture of the ECM change drastically with disease progression.